Contract Manufacturing of Oral Solids Market: By Product Type (Tablets, Capsules, Powders & Granules, Lozenges & Pastilles, Gummies), By End User (Big Pharma or Biotechnology Companies, Small & Medium Size Pharma/Biotech Companies, Emerging/virtual Pharma Companies, Nutraceutical Companies), and By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Contract Manufacturing of Oral Solids Market size was valued at USD x billion in 2022 and is expected to reach USD x billion by 2029, at a CAGR of x% during the forecast period 2023 to 2029 owing to increase in outsourcing by the innovator companies on branded products results in approximately 40% to 60 % cost savings to the company and are expected to drive the growth of the market. Moreover, increasing number of contract manufacturing organizations coupled advanced manufacturing technologies fuels the growth of the market. However, high supplier switching cost and risks related to data confidentiality and exclusivity are expected to hamper the growth of the market. The report studies global contract manufacturing of oral solids market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. global contract manufacturing of oral solids market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

Global Contract Manufacturing Of Oral Solids Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

x%

Largest Market

Asia-Pacific

Fastest Growing Market

North-America
Contract Manufacturing of Oral Solids Market Dynamics

In contract manufacturing of oral solids, information such as product formula has to be transferred from client (innovator) companies to suppliers (CMOs) which involves the risk i.e. related to data confidentiality and exclusivity. The service provider after the completion of agreement might become the competitor for innovator for the particular product. Moreover, the buyers have to pay high switching cost to the service providers due to need for compatibility with the manufacturing equipment required that is expected to limit the growth of the contract manufacturing of oral solids market.

Key Features of the Reports

  • Global contract manufacturing of oral solids market expanding at significant CAGR over 2023 to 2029 owing to increasing number of contract manufacturing organizations across the globe.
  • Based on product type, tablets segment contract manufacturing of oral solids accounted for larger market revenue share in 2022 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global contract manufacturing of oral solids market

Global Contract Manufacturing Of Oral Solids Market Segmentation

By Product Type

Tablets

  • Conventional/Immediate Release
  • Modified Release
  • Effervescent Tablets
  • Chewable Tablets

Capsules

  • Soft Gelatin Capsules/Soft gels
  • Hard Gelatin Capsules

Powders & Granules Lozenges & Pastilles Gummies

By End User
  • Big Pharma or Biotechnology Companies
  • Small & Medium Size Pharma/Biotech Companies
  • Emerging/virtual Pharma Companies
  • Nutraceutical Companies
By Geography
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa 
LOCATION

Geography

Frequently Asked Questions

The key segments covered in the Contract Manufacturing of Oral Solids Market are: by product type and by end user

The Contract Manufacturing of Oral Solids Market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.

North America is the fastest-growing for Contract Manufacturing of Oral Solids Market

1. Executive Summary

2. Global Contract Manufacturing of Oral solids Market Introduction

2.1. Global Contract Manufacturing of Oral solids Market Taxonomy

2.2. Global Contract Manufacturing of Oral solids Market Definitions

2.2.1. By Product Type

2.2.2. By End User

3. Global Contract Manufacturing of Oral solids Market Dynamics

3.1. Drivers

3.2. Restraints

3.3. Opportunities/Unmet Needs of the Market

3.4. Trends

3.5. Global Contract Manufacturing of Oral solids Market Dynamics Factors Impact Analysis

4. Global Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

4.3. Market Opportunity Analysis

5. Global Contract Manufacturing of Oral solids Market Forecast, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029

5.1. Tablets

5.1.1. Conventional/Immediate Release

5.1.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.1.3. Market Opportunity Analysis

5.1.2. Modified Release

5.1.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.2.3. Market Opportunity Analysis

5.1.3. Effervescent Tablets

5.1.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3.3. Market Opportunity Analysis

5.1.4. Chewable Tablets

5.1.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.4.3. Market Opportunity Analysis

5.2. Capsules

5.2.1. Soft Gelatin Capsules/Soft gels

5.2.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.1.3. Market Opportunity Analysis

5.2.2. Hard Gelatin Capsules

5.2.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.2.3. Market Opportunity Analysis

5.3. Powders & Granules

5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.3.3. Market Opportunity Analysis

5.4. Lozenges & Pastilles

5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.4.3. Market Opportunity Analysis

5.5. Gummies

5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.5.3. Market Opportunity Analysis

6. Global Contract Manufacturing of Oral solids Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029

6.1. Big Pharma or  Biotechnology Companies

6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Small & Medium Size Pharma/Biotech Companies

6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Emerging/virtual Pharma Companies

6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

6.4. Nutraceutical Companies

6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.4.3. Market Opportunity Analysis

7. Global Contract Manufacturing of Oral solids Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029

7.1. North America

7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.1.3. Market Opportunity Analysis

7.2. Europe

7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.2.3. Market Opportunity Analysis

7.3. Asia Pacific

7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.3.3. Market Opportunity Analysis

7.4. Latin America

7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.4.3. Market Opportunity Analysis

7.5. The Middle East & Africa

7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)

7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

7.5.3. Market Opportunity Analysis

7.6. Global Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Region, 2023 - 2029

8. North America Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

8.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.1.1. Tablets

8.1.1.1. Conventional/Immediate Release

8.1.1.2. Modified Release

8.1.1.3. Effervescent Tablets

8.1.1.4. Chewable Tablets

8.1.2. Capsules

8.1.2.1. Soft Gelatin Capsules/Soft gels

8.1.2.2. Hard Gelatin Capsules

8.1.3. Powders & Granules

8.1.4. Lozenges & Pastilles

8.1.5. Gummies

8.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

8.2.1. Big Pharma or  Biotechnology Companies

8.2.2. Small & Medium Size Pharma/Biotech Companies

8.2.3. Emerging/virtual Pharma Companies

8.2.4. Nutraceutical Companies

8.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

8.3.1. U.S.

8.3.2. Canada

8.4. North America Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029

8.5. North America Contract Manufacturing of Oral solids Market Dynamics Trends

9. Europe Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

9.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.1.1. Tablets

9.1.1.1. Conventional/Immediate Release

9.1.1.2. Modified Release

9.1.1.3. Effervescent Tablets

9.1.1.4. Chewable Tablets

9.1.2. Capsules

9.1.2.1. Soft Gelatin Capsules/Soft gels

9.1.2.2. Hard Gelatin Capsules

9.1.3. Powders & Granules

9.1.4. Lozenges & Pastilles

9.1.5. Gummies

9.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

9.2.1. Big Pharma or  Biotechnology Companies

9.2.2. Small & Medium Size Pharma/Biotech Companies

9.2.3. Emerging/virtual Pharma Companies

9.2.4. Nutraceutical Companies

9.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

9.3.1. U.K.

9.3.2. Germany

9.3.3. France

9.3.4. Italy

9.3.5. Spain

9.3.6. Russia

9.3.7. Rest of Europe

9.4. Europe Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029

9.5. Europe Contract Manufacturing of Oral solids Market Dynamics Trends

10. Asia Pacific Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

10.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.1.1. Tablets

10.1.1.1. Conventional/Immediate Release

10.1.1.2. Modified Release

10.1.1.3. Effervescent Tablets

10.1.1.4. Chewable Tablets

10.1.2. Capsules

10.1.2.1. Soft Gelatin Capsules/Soft gels

10.1.2.2. Hard Gelatin Capsules

10.1.3. Powders & Granules

10.1.4. Lozenges & Pastilles

10.1.5. Gummies

10.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

10.2.1. Big Pharma or  Biotechnology Companies

10.2.2. Small & Medium Size Pharma/Biotech Companies

10.2.3. Emerging/virtual Pharma Companies

10.2.4. Nutraceutical Companies

10.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

10.3.1. China

10.3.2. Japan

10.3.3. India

10.3.4. ASEAN Counties

10.3.5. Philippines

10.3.6. Rest of Asia Pacific

10.4. Asia Pacific Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029

10.5. Asia Pacific Contract Manufacturing of Oral solids Market Dynamics Trends

11. Latin America Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

11.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.1.1. Tablets

11.1.1.1. Conventional/Immediate Release

11.1.1.2. Modified Release

11.1.1.3. Effervescent Tablets

11.1.1.4. Chewable Tablets

11.1.2. Capsules

11.1.2.1. Soft Gelatin Capsules/Soft gels

11.1.2.2. Hard Gelatin Capsules

11.1.3. Powders & Granules

11.1.4. Lozenges & Pastilles

11.1.5. Gummies

11.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

11.2.1. Big Pharma or  Biotechnology Companies

11.2.2. Small & Medium Size Pharma/Biotech Companies

11.2.3. Emerging/virtual Pharma Companies

11.2.4. Nutraceutical Companies

11.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

11.3.1. Mexico

11.3.2. Brazil

11.3.3. Argentina

11.3.4. Chile

11.3.5. Rest of Latin America

11.4. Latin America Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029

11.5. Latin America Contract Manufacturing of Oral solids Market Dynamics Trends

12. Middle East and Africa Contract Manufacturing of Oral solids Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029

12.1. Product Type Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.1.1. Tablets

12.1.1.1. Conventional/Immediate Release

12.1.1.2. Modified Release

12.1.1.3. Effervescent Tablets

12.1.1.4. Chewable Tablets

12.1.2. Capsules

12.1.2.1. Soft Gelatin Capsules/Soft gels

12.1.2.2. Hard Gelatin Capsules

12.1.3. Powders & Granules

12.1.4. Lozenges & Pastilles

12.1.5. Gummies

12.2. End User Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)

12.2.1. Big Pharma or  Biotechnology Companies

12.2.2. Small & Medium Size Pharma/Biotech Companies

12.2.3. Emerging/virtual Pharma Companies

12.2.4. Nutraceutical Companies

12.3. Country Analysis (2018 - 2022) and Forecast (2023 - 2029) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)

12.3.1. GCC Countries

12.3.2. South Africa

12.3.3. Saudi Arabia

12.3.4. Turkey

12.3.5. Rest of MEA

12.4. Middle East and Africa Contract Manufacturing of Oral solids Market - Opportunity Analysis Index, By Product Type, By End User, and Country, 2023 - 2029

12.5. Middle East and Africa Contract Manufacturing of Oral solids Market Dynamics Trends

13. Competition Landscape

13.1. Strategic Dashboard of Top Market Players

13.2. Company Profiles (Introduction, Financial Analysis, Key Developments, Strategies, and SWOT Analysis)

13.2.1. Recipharm AB

13.2.2. AbbVie Contract Manufacturing

13.2.3. Patheon N.V.

13.2.4. Catalent Inc.

13.2.5. NextPharma

13.2.6. Capsugel (Lonza Group AG)

13.2.7. Aurobindo Pharma Limited (AuroSource)

13.2.8. Siegfried AG

13.2.9. Piramal Pharma Solutions

13.2.10. CordenPharma

14. Research Methodology

15. Key Assumptions and Acronyms

  • Recipharm AB
  • AbbVie Contract Manufacturing
  • Patheon N.V.
  • Catalent Inc.
  • NextPharma
  • Capsugel (Lonza Group AG)
  • Aurobindo Pharma Limited (AuroSource)
  • Siegfried AG
  • Piramal Pharma Solutions
  • CordenPharma

Adjacent Markets